Genetic Technologies Limited announced this week the successful completion of two ground-breaking tests branded GeneType for Colorectal Cancer and GeneType for Breast Cancer. The two new tests follow substantial scientific research and genetic product development. According to the company’s press release, the company’s “polygenic risk tests combine information from genetic markers called Single Nucleotide Polymorphisms … Continue reading “Genetic Technologies Limited Announces Completion of Two Genetic Risk Tests for Colorectal Cancer and Breast Cancer”
Biotech & Pharma
Biotech & Pharma
AstraZeneca and Merck’s Breast Cancer Drug Lynparza Gets EU Approval
AstraZeneca plc AZN and partner Merck announced this week that the European Commission has approved…
April 11, 2019
Biotech & Pharma
AstraZeneca Acquires Joint Development and Commercialization Rights to a Very Exciting Cancer Candidate
AstraZeneca (AZN) announced this week that it has acquired joint development and commercialization rights to…
March 30, 2019
Biotech & Pharma
Pfizer Is Buying a Big Stake in This Company
Pharmaceutical giant Pfizer Inc. announced that it is buying a stake in French gene company…
March 22, 2019
Biotech & Pharma
FDA Grants Accelerated Approval for Roche Holdings Tecentriq Drug for Breast Cancer
It was this week that Roche Holdings AG RHHBY announced that the Food and Drug…
March 14, 2019
Biotech & Pharma
Johnson & Johnson Gets Approval from FDA for Nasal Spray Antidepressant
It was a day of celebration for Johnson & Johnson on Tuesday after the pharmaceutical…
March 6, 2019
Biotech & Pharma
The Maker of OxyContin Explores Filing For Bankruptcy
Purdue Pharma LP, the company that makes OxyContin, is exploring bankruptcy according to sources familiar…
March 5, 2019
Biotech & Pharma
Johnson & Johnson May Soon Gain FDA Approval for Blockbuster Depression Drug
Pharmaceutical giant Johnson & Johnson could be on the cusp of gaining approval from the…
February 13, 2019
Biotech & Pharma
Bristol-Myers Has Withdrew its Application for Combination Lung Cancer Treatment
Bristol-Myers Squibb Co had a surprising announcement on Thursday as it reported financial results. The…
January 24, 2019
Biotech & Pharma
Johnson & Johnson Beats in Fourth Quarter
Johnson & Johnson reported its fourth quarter financial report ahead of the bell on Tuesday.…
January 22, 2019
Biotech & Pharma
Eli Lilly to Acquire Loxo Oncology for $8 Billion
Eli Lilly has announced that it will be acquiring Loxo Oncology for around $8 billion…
January 7, 2019
Biotech & Pharma
Pfizer to Raise the Prices of 41 Prescription Drugs in January
Despite criticism from President Trump about increasing drug prices, Pfizer will be raising its prices…
November 17, 2018
Biotech & Pharma
Novartis is Buying Endocyte for $2.1 Billion
Pharmaceutical giant Novartis is making a big purchase. The Swiss company is purchasing U.S. Endocyte…
October 18, 2018
Biotech & Pharma
This Startup Can Detect a Dangerous Blood Condition Through Heart Signals
AliveCor, a start-up medical device and artificial intelligence company that sells ECG hardware and software…
September 11, 2018